OS THERAPIES INCORPORATED Shares Outstanding (Cover Page)
OS THERAPIES INCORPORATED (OSTX) had Shares Outstanding (Cover Page) of 46.13 million shares as of 2026-08-12, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-12: Entity Common Stock, Shares Outstanding 46.13M shares.
- 2026-05-14: Entity Common Stock, Shares Outstanding 44.54M shares.
- 2026-03-26: Entity Common Stock, Shares Outstanding 39.53M shares.
- 2025-11-14: Entity Common Stock, Shares Outstanding 35.21M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 46.13M shares 10-Q · filed 2026-08-14 |
| 2026-05-14 | 44.54M shares 10-Q · filed 2026-05-18 |
| 2026-03-26 | 39.53M shares 10-K · filed 2026-03-31 |
| 2025-11-14 | 35.21M shares 10-Q · filed 2025-11-14 |
| 2025-08-13 | 31.89M shares 10-Q · filed 2025-08-18 |
| 2025-05-13 | 28.10M shares 10-Q · filed 2025-05-15 |
| 2025-03-28 | 21.66M shares 10-K · filed 2025-03-31 |
| 2024-11-11 | 21.24M shares 10-Q · filed 2024-11-15 |
| 2024-08-14 | 20.88M shares 10-Q · filed 2024-08-14 |
| 2024-05-09 | 11.98M shares 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |